Abstract
Abdominal aortic aneurysm (AAA), a common disease among elderly individuals, involves the progressive dilatation of the abdominal aorta as a consequence of degeneration. The mechanisms of AAA formation, development and rupture are largely unknown. Surgical repair is the only available method of treatment since the lack of knowledge regarding the pathogenesis of AAA has hindered the development of suitable medical treatments, particularly the development of drugs. In this review, we describe the inflammatory cells and proteases that may be involved in the formation and development of AAA. This knowledge can contribute to the development of new drugs for AAA.
Keywords: Abdominal aortic aneurysm, inflammatory cells, proteases, extracellular matrix, macrophages, atherosclerosis.
Current Drug Targets
Title:Inflammatory Cells and Proteases in Abdominal Aortic Aneurysm and its Complications
Volume: 19 Issue: 11
Author(s): Haiying Jiang, Takeshi Sasaki, Enze Jin, Masafumi Kuzuya and Xian Wu Cheng*
Affiliation:
- Department of Cardiology and Heart Center/Hypertension, Yanbian University Hospital, Yanji 133000, Jilin Prov.,China
Keywords: Abdominal aortic aneurysm, inflammatory cells, proteases, extracellular matrix, macrophages, atherosclerosis.
Abstract: Abdominal aortic aneurysm (AAA), a common disease among elderly individuals, involves the progressive dilatation of the abdominal aorta as a consequence of degeneration. The mechanisms of AAA formation, development and rupture are largely unknown. Surgical repair is the only available method of treatment since the lack of knowledge regarding the pathogenesis of AAA has hindered the development of suitable medical treatments, particularly the development of drugs. In this review, we describe the inflammatory cells and proteases that may be involved in the formation and development of AAA. This knowledge can contribute to the development of new drugs for AAA.
Export Options
About this article
Cite this article as:
Jiang Haiying , Sasaki Takeshi , Jin Enze , Kuzuya Masafumi and Cheng Wu Xian*, Inflammatory Cells and Proteases in Abdominal Aortic Aneurysm and its Complications, Current Drug Targets 2018; 19 (11) . https://dx.doi.org/10.2174/1389450119666180531103458
DOI https://dx.doi.org/10.2174/1389450119666180531103458 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial
Current Medical Imaging Demystifying the ACE Polymorphism: From Genetics to Biology
Current Pharmaceutical Design Electroconvulsive Therapy in Child and Adolescent Psychiatry
Current Psychiatry Reviews The Extracellular Matrix of Blood Vessels
Current Pharmaceutical Design Cardiovascular Imaging in Thromboembolic Risk Stratification for Atrial Fibrillation: Recent Patents and Current Practice
Recent Patents on Medical Imaging Diagnosis and Management of Endocrine Hypertension in Children and Adolescents
Current Pharmaceutical Design CCR2 Antagonists
Current Topics in Medicinal Chemistry Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy
Current Drug Targets Cell Immunity in Inflammatory Vasculitis
Current Immunology Reviews (Discontinued) MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Cardiac Disease
Recent Patents on Biomarkers Beta-blockers in Intensive Care Medicine: Potential Benefit in Acute Brain Injury and Acute Respiratory Distress Syndrome
Recent Patents on Cardiovascular Drug Discovery Safety of Intravenous Thrombolysis in Ischemic Stroke Caused by Left Atrial Myxoma
Current Drug Safety Anti-Platelet Treatment of Middle-Sized Abdominal Aortic Aneurysms
Current Vascular Pharmacology Gender as a Regulator of Atherosclerosis in Murine Models
Current Drug Targets Cerebrovascular Amyloidosis and Dementia
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Heparin-Coated Extracorporeal Circulation Systems in Heart Surgery
Recent Patents on Cardiovascular Drug Discovery Late-Onset Glycogen Storage Disease Type 2
Current Molecular Medicine Therapeutic Moderate Hypothermia and Fever
Current Pharmaceutical Design <i>In silico</i> Approach for Exploring the Role of AT1R Polymorphism on its Function, Structure and Drug Interactions
Current Computer-Aided Drug Design Early Cerebral Infarction Following Aneurysmal Subarachnoid Hemorrhage: Frequency, Risk Factors, Patterns, and Prognosis
Current Neurovascular Research